“Cultivated meat is the most important landmark invention of our time, and bioreactors are critical to actualizing this historic change,” the report reads. A significant portion of bioreactor costs are fixed and most variable costs scale at a factor, says the report. “Reducing bioreactor spend is critical for reducing capital cost.”

Source: Path to Price Parity: Ark Biotech’s Plan for Affordable Cultivated Meat – Green Queen